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Vitamin A (VA, retinol) is an essential nutrient found naturally in several foods. VA supports several functions in the body such as vision, growth, reproduction, and maintenance and differentiation of epithelial tissues. Over-thecounter VA supplements are often used for general health promotion and prophylaxis against common cold. It is also used therapeutically for the treatment of skin conditions such as acne and psoriasis, and for cancer chemoprevention. About 35-50% of adults in the United States regularly consume vitamin A supplements (McDonald, 1986) . Acute or chronic intake of large doses of VA can result in hepatotoxicity. Even therapeutic doses of VA taken for 2-15 years have been shown to produce liver damage. In patients who had chronic hypervitaminosis A, the mean daily intake of VA in patients who had cirrhosis was 135,000 IU/day, while that in patients with noncirrhotic liver disease was 66,000 IU/ day (Guebel et al., 1991) . There is a recent report that indicates that even lower daily, over-the-counter VA supplements can cause liver disease. For example, intake of 25,000 IU/day supplement resulted in reversible hepatotoxicity (Kowalski et al, 1994) .
Vitamin A toxicity can be modulated by simultaneous exposure to environmental chemicals, drugs, food substances, and other dietary supplements. VA pretreatment for 7 days potentiated the hepatotoxicity of CC1 4 (ElSisi et al., 1993a,b) , allyl alcohol, acetaminophen, and endotoxin (ElSisi et al., 1993a) . Recent investigations have demonstrated that 1-day pretreatment of VA also resulted in the enhancement of CCU hepatotoxicity in rats (Badger et al., 1995) . VA also increases ethanol hepatotoxicity in rats (Leo et al., 1982) . Simultaneous exposure of rats to a nonhepatotoxic level of VA and ethanol for 9 months resulted in liver damage as indicated by an increase in liver enzymes in the serum as well as morphologic changes such as cellular infiltration, loss of hepatocytes, mitochondrial damage in hepatocytes, and fibrosis (Anonymous, 1983) . The mechanism by which VA increased the toxicity of the chemicals discussed above is not fully known. However, VA is thought to prime Kupffer cells (Mobley et al, 1991) in such a way that treatment with a hepatotoxicant results in a greater release of cytotoxic mediators by the VA-primed Kupffer cells resulting in greater damage. Kupffer cells, the resident macrophages of the liver, may play a role in the potentiation of CCU-induced toxicity. It has been shown that the inactivation of Kupffer cells by treatment with gadolinium chloride reduces CC1 4 -induced liver injury (Edwards et al., 1993) . Gadolinium chloride causes disintegration of Kupffer cells, thereby caus- 
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Note. Different quantities of VDC dissolved in DMSO were injected onto a paper wick suspended inside vials containing 1.7 ml Waymouth's medium and incubated for 30 min or 1 or 2 hr. An aliquot of the medium was analyzed by gas chromatography as described under Materials and Methods. VDC concentrations in the media are shown as the means of the concentrations at different times of incubation (n = 6).
ing a drastic reduction in their numbers (Hardonk et al., 1992) . In addition, ElSisi et al. (1993c) showed that methyl palmitate blocked the VA potentiation of CC1 4 hepatotoxicity.
Vinylidene chloride (VDC) is a chlorinated hydrocarbon which is used as a degreasing agent and for the manufacture of Saran-type plastics. VDC causes hepatotoxicity in laboratory rodents (Jaeger et al., 1974; Andersen et al., 1979; Andersen and Jenkins, 1977; Reynolds et al., 1980; Jenkins and Andersen, 1978) . It is present as a contaminant in the ground water (Office of Technology Assessment, 1984) . In some parts of the country, the amounts of VDC in ground water far exceeds the maximum contaminant level (MCL) for VDC set by the EPA, which is 7 ppb. For example, concentrations up to 21,000 ^xg/liter VDC (21 ppm) have been reported in Arizona (Graf, 1986) . Because 50% of the U.S. population relies on ground water as the source of drinking water, there is a potential for the coexposure of VA and VDC. VDC has been identified as a contaminant in chlorinated drinking water and has been ranked 11th in the United States as a hazardous chlorinated organic substance in drinking water (Deinzer et al., 1978) . VDC has been 
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FIG. 1. Cytotoxicity of VDC in rat liver slices. One hour after preincubation liver slices were exposed to 0.025-1.0 y\ VDC for 2, 4, or 8 hr. Control slices were incubated without VDC. *, indicates significantly different from the control.
reported in the tap water from several locations in this country (Eurocop-Cost, 1976; Wallace et al, 1986) .
The present study was undertaken in order to examine whether VA pretreatment enhances VDC hepatotoxicity using an in vitro system of precision-cut rat liver slices, and also in vivo, and to determine the mechanisms responsible for this potentiation. The purpose of this study is to examine whether VA increases VDC hepatotoxicity and, if so, the role of Kupffer cells and cytochrome P450IIE1 in the VA enhancement of VDC hepatotoxicity.
MATERIALS AND METHODS
Materials. VDC and GdCl 3 were purchased from Aldrich (Milwaukee, Wl). Vitamin A (retinol) was obtained as Aquasol from Armour Pharmaceutical (Kankakee, IL). Vehicle control for VA consisted of water, propylene glycol, and Tween 20 in the ratio of 83:10:7.
Animals. Male Sprague-Dawley rats (250-275 g) were purchased from Harlen (Indianapolis, IN). The animals were allowed to acclimatize for 1 week before use. Food and water were freely available to the rats.
In vivo studies. To determine the effects of VA pretreatment on VDC hepatotoxicity, rats were administered 250,000 IU/kg (75 mg/kg) VA by pretreatment on VA-potentiated VDC toxicity of liver slices. Rats were pretreated with GdCl 3 (10 mg/kg iv) or NaCl before VA (250,000 IU/kg po). Liver slices were prepared 24 hr after VA. One hour after preincubation liver slices were exposed to 0.25-1.0 /A VDC for 2, 4, or 8 hr. Control slices were incubated without VDC. oral gavage. Control rats received the VA vehicle. VDC was administered at 200, 100, or 50 mg/kg ip (in 4 ml peanut oil (PO)/kg) 24 hr after VA, while the controls received PO vehicle. One day after VDC rats were euthanized by an overdose of pentobarbital. For the determination of the role of Kupffer cells in VA potentialion of VDC toxicity, rats were pretreated with 10 mg/kg GdCl, (Aldrich Chemical Co.) in 2 ml saline iv through the tail vein or saline just before VA was administered. VDC was given 24 hr after VA and the animals were euthanized by cervical dislocation 24 hr after VDC. Blood was obtained from abdominal aorta for plasma ALT determination (Sigma Procedure No. 59-UV). Samples of liver from the median and lateral lobes were fixed in 10% neutral-buffered Formalin, processed for histological sectioning. Liver sections (6 fj.m) were stained with hematoxylin and eosin (H&E). One liver section from each lobe was examined under the microscope.
In vitro studies. Rats received VA or vehicle on Day 1 as mentioned in in vivo studies. On Day 2, rats were euthanized by cervical dislocation.
To examine the role of Kupffer cells in the VA potentiation of VDC toxicity, rats were pretreated with GdCl, (as described in in vivo studies) just before VA was given on Day 1. Rats were euthanized on Day 2. The liver was excised and placed in ice-cold Kreb's Hensleit buffer.
Liver slices were prepared as previously described (Wijeweera et al, 1995) . Briefly, liver slices (250-300 /im) were prepared from cylindrical cores of liver tissue of 10 mm diameter, using a Krumdieck tissue slicer (Alabama Research and Development Corporation, Munsford, AL). Liver slices were stored in cold Kreb's Hensleit buffer that had been gassed with 95%O2/5%CO 2 until used. Two liver slices were loaded onto a semicircular stainless-steel screen with two steel rings at each end and the screen was placed in a glass scintillation vial containing 1.7 ml Waymouth MB751/2 to which 0.5% gentamycin has been added and gassed with 95%O2/5%CO2 for 30 min before use. The vials were gassed with 95%Oj/5%CC>2 and incubated at 37°C on a roller incubator as previously described (Smith et al., 1986) . Liver slices from control or treated rats were exposed to different concentrations of VDC for 2, 4, or 8 hr after 1 hr preincubation.
Two series of experiments were performed wirh different amounts of VDC. VDC was evaporated into the head space (22 ml) of the incubation vial. In one set of experiments the volumes of VDC used were 0.25, 0.5, or 1.0 /il. In the other set, the amounts of VDC used were 0.025, 0.05, or 1.0 /il. VDC was diluted in DMSO to obtain proper concentrations and injected onto a paper wick mounted on a pin passing through the septum fitted to the cap of the vial. Exposure to DMSO alone did not affect the slice viability. Slice viability was assessed by the measurement of the leakage of intracellular K + (Azri et al., 1990) . The slice K + content was normalized to the DNA content which was determined according to Kissane and Robbins (1958) , and the values were expressed as nmol K + //jg DNA. Liver slices exposed to the lower concentrations of VA were fixed in 10% neutral-buffered Formalin and processed for histology, and the sections were stained with H&E.
Measurement of VDC in the media.
The quantity of VDC partitioned mto the media was measured by gas chromatography. VDC mixed with DMSO was injected onto a paper wick suspended inside the vial containing 1.7 ml Waymouth's medium and incubated for 0.5, 1, or 2 hr. An aliquot of 0.25 ml of the media was removed from vials by a gas-tight syringe and placed in a 1.0-ml reaction vial through a septum in the cap. The vials were heated at 40°C for 30 min. An aliquot of the gas phase (0.25 ml) was injected into a 6 ft x j in. Poropack-QS 80/100 column (Supelco, Bellefonte, PA) on a HP5890 gas chromatograph with flame ionization detection. The limit of detection was 0.5 nM. The experiment was repeated three times with two samples for each condition. 
Note. Rats were pretreated with VA (250,000 IU/kg) 24 hr before preparation of liver slices. Liver slices were exposed to 0.025-1.0 /il VDC for 2, 4, or 8 hr. Control slices were incubated without VDC. Liver slices were fixed in 10% Formalin, processed for light microscopy, and stained with H& E (n = 3, two liver slices from each rat were used for each condition). Effects of VA on cytochrome P4S0 activity as detected by PNP hydroxylation by liver slices. PNP hydroxylation was performed according to methods described previously (Koop, 1986; Reinke and Moyer, 1985) , with a few modifications. Liver slices were prepared from VA-or vehicle-pretreated or cytochrome P450ILEI -induced rats by treatment with 100 mg/kg pyridine ip 24 hr earlier (Kim and Novak, 1990) . Twenty slices from each rat were blotted and placed in a 25-ml Erlenmyer flask with a raised bottom, containing 5 ml RPMI 1640 medium (pH 7.4) without phenol red (Gibco BRL, Grand Island, NY) to which 100 fiM />-nitrophenol (Calbiochem, San Diego, CA) has been added. Twenty slices were used to provide enough biotransformation activity for this assay. The flasks were incubated at 37°C for 15 min in an orbital shaker (75 rpm). Flasks were placed on ice after incubation. Slices were blotted and placed in 2 ml deionized water and homogenized by sonication. The medium was decanted into a test tube, 6000 5000 4000 H 3000
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TREATMENT 10 11 FIG. 5. Plasma ALT levels of rats exposed to VDC. Rats were pretreated with VA or GdCl 3 + VA, 24 hr before 50, 100, or 200 mg/kg VDC. Control rats received the vehicle. * indicates significantly different from vehicle +50 mg/kg VDC. ** indicates significantly different from VA + 50 mg/kg VDC. (Error bars are not shown for treatment groups 4 and 7 because one animal survived in each group. For treatment groups 1, 2, 9, and 11 the error bars are too small ) centnfuged for 10 min at 10,000 rpm. To 1 ml of the medium, 0.1 ml of 10 M NaOH was added and centrifuged again. The absorbance of the supernatant fraction was determined at 510 nm. A standard curve was prepared from 4-nitrocatechol (Sigma Chemical Co., St. Louis, MO). The protein content of the slice homogenate was determined by BCA method (Sigma Chemical Co.).
Effects of VA on cytochrome P4S0HE1 protein content as determined by Western blot analysis. Slice homogenate from above was centrifuged at 10,000g for 20 min and the supernatant fraction was used for the analysis. Forty micrograms of protein from VA-treated and control slices was loaded onto different lanes of a 10% gel, and the proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to Leammli (1970) . Western blot analysis was performed according to previously described methods (Kjm and Novak, 1990; Ryan el al., 1985) . Slice proteins from a pyridine-treated rat was loaded onto one lane as a positive control for cytochrome P450IIE1 protein. The proteins were transferred to PVDF paper (Millipore, Bedford, MA) and electrophoretic transfer of proteins was performed. The blots were incubated with goat anti-human cytochrome P450IIEI antibody at a dilution of 1:1000 (Oxford Biomedical Research Inc., Oxford, MI). After incubation with peroxidase-conjugated secondary antibody (horse anti-goat IgG, Vector, Burlingame, CA) at a dilution of 1:2000 the bands were visualized by reaction with DAB. Densitometric analysis of the bands was performed using Bio Image Whole Band Analysis 3.2.1 Program (Ann Arbor, MI).
Effects of inhibition of cytochrome P450IIE1 on VA potentiated VDC hepatotoxicity in vivo. Diallyl sulfide (DAS) is a known inhibitor of cytochrome P450IIEI (Brady et al., 1991; Chen et al., 1994; Morimoto el al.. 1995) . Therefore, in order to investigate the role of cytochrome P45OIIE1 in the VA potentiation of VDC hepatotoxicity, rats were pretreated with VA 24 hr before the administration of 50 mg/kg VDC. Four hours before VDC, rats were treated with 100 mg/kg DAS in 1 ml com oil (CO) ip. Control rats received the vehicle treatments. Twenty-four hours after VDC rats were euthanized by an overdose of pentobarbital, and blood was collected from the abdominal aorta for the determination of plasma ALT.
Statistical analysis. Results were analyzed using ANOVA and the means were compared by Dunn's multiple comparison test, p < 0.05 was taken as significant. For the in w'w study, n = 4-5. For the in vitro study, n = 3-4. Four liver slices were used at each time point and for each condition.
RESULTS

VDC Concentrations in the Media
The VDC concentration in the media was analyzed 0.5, 1, and 2 hr after incubation. The VDC in the media remained constant up to 2 hr with little variability (Table 1 ). For the ease of presentation, the quantities of VDC used in the in vitro experiments will be presented as the volumes injected into the vials.
Effects of VDC on Liver Slices
At 8 hr, 0.1 -1.0 fA VDC resulted in a significant decrease in slice viability (Fig. 1) . Exposure to VDC quantities of 0.025-0.05 //I VDC did not have a statistically significant effect on the slice K + contents.
Effects of VA Pretreatment on VDC Toxicity in Liver Slices
VA pretreatment significantly increased the toxicity of 0.10 y\ VDC at 2, 4, and 8 hr compared to both the vehicle control and VA treatment alone (Fig. 2) . The toxicity of 0.05 fi\ VDC was significantly increased at 8 hr compared to VA alone, while VA did not cause a significant K + leakage in slices exposed to 0.025 fi\ VDC.
Effects of GdCl 3 and VA Pretreatment on VDC Toxicity in Liver Slices
GdCl 3 + VA pretreatment alone did not affect the viability of liver slices (Fig. 3) . At 4 hr, intracellular K + concentration in slices exposed to VA + 0.1 fj\ VDC was decreased to 29% of the control value. With GdCl 3 pretreatment, K + / DNA was elevated to 53% of the control. A similar reversal by GdCl 3 of VA-potentiated toxicity of 0.05 y\ VDC was observed at 4 hr (64% decrease after VA, which was elevated to 96% after GdCl 3 ). At 8 hr, GdCl 3 did not reverse the VApotentiated toxicity of 0.1 ^1 VDC. However, at 8 hr, the increase in the leakage of K + caused by VA + 0.05 fi\ VDC (46%) was reversed by GdCI 3 (71 %). Similarly, VA induced K + leakage of 0.025 ^\ VDC was reversed from 75% to the control value at 8 hr.
Histological Analysis of Liver Slices
Grading of the centrilobular necrosis in liver slices after VDC is summarized in Note. Rats were pretreated with vehicle (C), VA (250,000 IU/kg), or GdCI 3 (10 mg/kg) + VA 24 hr before VDC. Rats were euthanized 24 hr after VDC and the livers were fixed in 10% Formalin, processed for light microscopy, and stained with H&E. from vehicle pretreated rats no lesions were observed up to 4 hr, while minimal necrotic lesions were observed at 8 hr with exposure to 0.025 fil or 0.05 /xl VDC. In liver slices exposed to 0.1 //I VDC minimal lesions are observed at 4 hr, while the lesions progressed mainly to moderate necrosis at 8 hr.
VA alone did not cause any necrotic changes up to 8 hr (Fig. 4A) , except fatty accumulations in some hepatocytes. Pretreatment with VA markedly increased the extent of the necrotic lesions after exposure to VDC. The extent of the centrilobular lesion increased with the quantity of VDC and the time of exposure. Exposure to 0.025 /xl VDC resulted in a few necrotic cells near the central veins (minimal necrosis) and the appearance of vacuolation in the midzonal hepatocytes. In slices exposed to 0.05 fj.1 VDC minimal necrotic changes were seen with increases in the vacuolar changes in the midzonal area (Fig. 4B) . At 4 hr treatment with 0.025 //I VDC resulted in mild necrotic changes (Fig. 4C ) which progressed to moderate necrosis at 8 hr. Liver slices exposed to 0.05 /zl VDC, minima] changes were seen at 2 hr, while at 4 hr lesions increased to moderate (Fig. 4D) or marked. At 8 hr, with the above treatment all slices were affected severely (Fig. 4E) . With 0.1 fi\ VDC exposure, liver slices had moderate lesions as early as 2 hr. At 4 and 8 hr all liver slices had severe necrotic lesions.
Effects of VA and GdCl 3 + VA Pretreatments on VDC Hepatotoxicity in Vivo
VA alone did not cause any hepatotoxicity (Fig. 5) . In rats treated with 200 mg/kg VDC aJone one animal had slightly elevated ALT (358 IU/liter). Treatment with 100 mg/ kg VDC alone did not result in any toxicity. VA pretreatment greatly enhanced the hepatotoxicity of both 200 and 100 mg/ kg VDC. Mortality in the group which received VA + 200 mg/kg VDC was 4/5 at 24 hr, and in the group which received VA + 100 mg/kg VDC 3 of 4 died after 24 hr. Treatment with GdCl 3 alone did not result in an elevation of ALT (results not shown). In the group of animals that received GdCl 3 + VA + 200 mg/kg VDC, 2/4 rats died after 24 hr. The ALT levels of the animals which survived after the above treatment were decreased by only 14% compared to VA + 200 mg/kg VDC treatment. Pretreatment with GdCl 3 decreased the VA potentiated hepatotoxicity of VA + 100 mg/kg VDC. All animals which received GdCl 3 + VA + 100 mg/kg VDC survived. The ALT levels of these animals were decreased by 72% compared to VA + 100 mg/kg VDC-treated animals.
Since VA caused mortality in 100 and 200 mg/kg VDCtreated rats, the effects of VA or GdCl 3 + VA on 50 mg/ kg VDC was studied. Treatment with 50 mg/kg VDC had no effect on ALT. Pretreatment with VA significantly elevated ALT compared to vehicle + 50 mg/kg VDC. GdCl 3 pretreatment almost completely reversed the VA-induced hepatotoxicity in 50 mg/kg VDC-treated rats. The ALT levels of GdCl 3 + VA + 50 mg/kg VDC-treated rats were dropped to 93% lower than the value of VA + 50 mg/kg VDC treatment.
Histological Analysis of the Liver
VA pretreatment resulted in centrilobular necrosis of the livers of VDC treated rats at 24 hr (Table 3 ). In rats which received VA only (Fig. 6B ) the livers did not differ much from those of vehicle controls (Fig. 6A) , except that the former livers had some fatty accumulations in hepatocytes. Rats which received 50 or 100 mg/kg VDC had only minimal changes, which comprised of a few necrotic cells and an infiltration of a few inflammatory cells which consisted mainly of neutrophils around the central veins (Fig. 6C) . In the livers of rats which received 200 mg/kg VDC mild necrotic changes were observed which consisted of a few layers of necrotic cells around central veins and inflammatory cells (Fig. 6D) . VA pretreatment increased the extent of necrotic lesions depending on the dose of VDC. In VA + 50 mg/kg treated rats mild to moderate necrotic lesions are observed (Fig. 7A) while the rats which survived VA + 100 mg/kg VDC or VA + 200 mg/kg VDC exhibited marked (Fig. 7B) and severe (Fig. 7C ) centrilobular lesions, respectively. While GdCl 3 alone did not cause any pathological lesions in the liver (results not shown), pretreatment with it resulted in the reduction of the extent of the lesion in VA + VDC-treated rats. In rats which received GdCl 3 + VA + 50 mg/kg VDC, minimal necrotic lesions were observed (Fig. 7D) . In two of the rats which survived after GdCl 3 + VA + 100 mg/kg, the lesion severity decreased to moderate (Fig. 7E) . In two rats which survived after GdCl 3 + VA + 200 mg/kg VDC lesion severity decreased to marked necrosis (Fig. 7F) .
PNP Hydroxylation by Liver Slices
Both VA and pyridine pretreatment (Kim and Novak, 1990) , which result in the specific induction of cytochrome P450HE1, resulted in a twofold increase in PNP hydroxylation compared to control (Fig. 8) indicating that p-nitrophenol as well as VA increased the catalytic activity specific to cytochrome P450IIE1.
Western Blot Analysis of Cytochrome P450IIE1 in Liver Slices
Western blot analysis of cytochrome P450IIE1 protein indicated protein bands from control and VA pretreated rats corresponding to the band from pyridine pretreated rat (Fig.  9) . Densitometric analysis demonstrated that there is a 2.4-fold increase in the intensity of bands from VA-pretreated rats compared to the control rats. This correlated well with the increase in PNP hydroxylation seen in VA-pretreated liver slices.
Effects of Inhibition of Cytochrome P450IIE1 on VA Potentiated VDC Hepatotoxicity in Vivo
VA pretreatment resulted in a significant elevation of plasma ALT compared to vehicle treatment (Fig. 10) . DAS significantly decreased ALT in rats which received VA + FIG. 7 . Histological changes in the liver after VA + VDC or GdCl 3 + VA + VDC. Rats were treated with VA (250,000 IU po) and VDC was given 24 hr after VA. Another group of rats received GdCl 3 (10 mg/kg iv) just before treatment with VA and VDC was given 24 hr later. VDC compared to rats which received CO + VA + VDC. This indicated that when VA induced cytochrome P450IIE1 activity is inhibited by DAS, there was reversal of the VApotentiated VDC hepatotoxicity. 
DISCUSSION
VA alone did not cause any liver damage, either in vivo or in vitro. A single treatment of VA resulted in a significant increase in VDC hepatotoxicity, both in vivo and in vitro. At 8 hr, VDC alone resulted in toxic injury to liver slices, except the two lowest concentrations as indicated by increased loss of intracellular K + . VA pretreatment significantly enhanced the toxicity of lower concentrations of VDC in liver slices at earlier times. A similar increase in VDC hepatotoxicity is seen in the in vivo study. There was a massive increase in toxicity in the group of rats which received VA and the higher doses of VDC with an increase in mortality and a dramatic increase in plasma ALT in the rats which survived. There was no mortality in the group which received VA and the lower dose of VDC, although ALT levels were significantly elevated compared to the control.
VDC treatment results in centrilobular necrosis of the liver (Reynolds et ai, 1975) . Similar necrotic lesions were observed after VA pretreatment and exposure to VDC, both in vivo and in liver slices. The extent of the centrilobular lesions depended on the amount of VDC in the in vivo study, and on the quantity and the time of exposure to VDC in the in vitro study. Although VA + 0.025 /A VDC did not cause a significant K + leakage, mild to moderate necrotic lesions were observed in liver slices at 4 and 8 hr. This may be due to the fact that a comparatively smaller number of hepatocytes were damaged and the overall K + levels were not affected much. The necrotic lesions appear to be more severe in liver slices from VA-pretreated rats exposed to 0.05 and 0.1 fj\ VDC at 8 hr compared to the hepatic lesions observed in the in vivo study. This may be due to the fact that most of the VDC is exhaled unchanged in vivo. After ip administration of a 350 mg/kg dose of VDC, about 90% was exhaled as unchanged VDC (Jones and Hathway, 1978) , and the delivery of VDC to the liver may be limited. In our sealed incubation system VDC concentrations may not change much, especially the higher concentrations of VDC, thus causing more damage to liver slices. In rats which are treated with hepatotoxic chemicals such as CCL, (Edwards et ai, 1993) or VDC (Wijeweera, 1992) , there is recruitment of other macrophages and neutrophils into the liver which exacerbate the injury. However, in liver slices, the injury proceeded without additional inflammatory infiltrations into the tissue. However, Kupffer cells already present in VA-pretreated liver slices may have contributed to hepatocellular damage.
There may be several mechanisms responsible for the observed potentiation of VDC hepatotoxicity after VA pretreatment. VA is known to activate the Kupffer cells (Earnest et ai, 1986) , the resident macrophages of the liver, and they may have had a role in the observed liver injury in the present study. Activated Kupffer cells can produce reactive oxygen species (Mobley et ai, 1991) , cytokines (Laskin, 1990) , and proteolytic enzymes (Tanner et ai, 1981) which can cause damage to the hepatocytes. Immunohistochemical staining showed a significant increase in the number of Kupffer cells in the centrilobular region of the liver of rats given a single treatment of VA and CC1 4 compared to rats which received CCU alone, while GdCl 3 resulted in a drastic reduction in the number of Kupffer cells . Treatment of rats with polyethylene glycol-coupled superoxide dismutase or catalase has been shown to block CCL»-induced liver injury in VA-pretreated rats (ElSisi et al., 1993c) . Inactivation of Kupffer cells by treatment with GdCl 3 (Edwards et al., 1993) or methyl palmitate (ElSisi et al., 1993c) reversed VA-potentiated CCLt hepatotoxicity. In the present study, GdCl 3 pretreatment did not completely reverse VA-potentiated VDC hepatotoxicity either in vitro or in vivo. In the in vivo experiments, increase in plasma ALT was partially blocked and the centrilobular lesions were only decreased in size. In the in vitro experiments GdCl 3 resulted in a partial reversal of K + leakage from liver slices after VA and VDC. Thus, while Kupffer cells may play a role in potentiation, other mechanisms also may be responsible for the enhancement of VDC hepatotoxicity after VA pretreatment.
It is possible that a single treatment of VA may cause changes in the liver that alter bioactivation or the detoxication pathways of VDC. Conjugation with GSH is the major detoxication pathway for reactive VDC metabolites (Jones and Hathway, 1978) . Previous studies have shown that VA does not change the concentrations of hepatoprotective agents in the liver such as vitamin E or GSH (ElSisi et al., 1993b) . Therefore, the increase in toxicity of VDC after VA Effects of DAS treatment on VA-potentiated VDC hepatotoxicity in vivo. Rats were pretreated with VA 24 hr before the administration of 50 mg/kg VDC. Four hours before VDC, rats were treated with 100 mg/ kg DAS in 1 ml corn oil (CO) ip. Control rats received the vehicle treatments. Twenty-four hours after VDC rats were eutharized by an overdose of pentobarbital, and plasma ALT was measured. * indicates significantly different from vehicle + CO + VDC. ** indicates significantly different from VA + CO + VDC pretreatment appears not to result from a reduction in hepatic GSH. Similarly, because GdCl 3 does not increase liver GSH levels (Edwards et al, 1993) , partial protection seen after GdCl 3 cannot be due to an increase in the detoxication of VDC metabolites.
Since Badger et al. (1995 reported that a single treatment of rats with VA increased the concentration and activity of hepatic cytochrome P450HE1, we investigated whether such effects could be observed in liver slices. VA pretreatment increased both the cytochrome P450IIE1 protein content and its catalytic activity as studied by PNP hydroxylation in liver slices. Treatment with other chemicals such as pyridine for 1 day is known to induce cytochrome P450ITE1 contents in rat liver (Kim and Novak, 1990) . Other studies have shown that when rats were given a diet high in VA, they had increased levels of total cytochrome P450 (Leo et al., 1984) . VA treatment also induces P4502C7 isozyme in primary rat hepatocytes (Westin et al., 1993) and P450IIIA2 in rat liver (Murray et al., 1991) . Induction of cytochrome P450IIE1 by VA pretreatment can result in an increased bioactivation of VDC, resulting in an increase in the amount of toxic metabolites that cause damage to hepatocytes. Cytochrome P450 is localized in the centrilobular region of the liver (Baron et al., 1978) . This correlates well with our observation that the necrotic lesion is localized to this area of the liver in VApretreated rats or liver slices exposed to VDC. Inhibition of cytochrome P450IIE1 with DAS resulted in a complete reversal of VA potentiation of VDC hepatotoxicity, indicating that induction of cytochrome P450IIE1 by VA plays a role in the observed VA potentiation of VDC hepatotoxicity.
In summary, more than one mechanism may be responsible for the enhancement of VDC hepatotoxicity after VA pretreatment. It is clear that even a single treatment with VA can cause an increase in the toxicity of VDC, and this may be true for other toxicants as well. This may have important consequences especially in people who consume large daily doses of over-the-counter VA supplements because there is possible exposure to environmental contaminants and other drugs which may interact to cause liver damage.
